Global Pediatric Drugs and Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pediatric Drugs and Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
Pediatric Drugs and Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pediatric Drugs and Vaccines market is projected to reach US$ 176440 million in 2034, increasing from US$ 95480 million in 2022, with the CAGR of 9.0% during the period of 2024 to 2034. Demand from Newborn and Infant are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pediatric Drugs and Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pediatric Drugs and Vaccines key manufacturers include Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA) and Actelion Pharmaceuticals, etc. Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA) are top 3 players and held % sales share in total in 2022.
Pediatric Drugs and Vaccines can be divided into Diphtheria, Influenza, Hepatitis and Pneumococcal Diseases, etc. Diphtheria is the mainstream product in the market, accounting for % sales share globally in 2022.
Pediatric Drugs and Vaccines is widely used in various fields, such as Newborn, Infant and Child,, etc. Newborn provides greatest supports to the Pediatric Drugs and Vaccines industry development. In 2022, global % sales of Pediatric Drugs and Vaccines went into Newborn filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Drugs and Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Newborn
Infant
Child
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pediatric Drugs and Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pediatric Drugs and Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pediatric Drugs and Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pediatric Drugs and Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pediatric Drugs and Vaccines introduction, etc. Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pediatric Drugs and Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Pediatric Drugs and Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pediatric Drugs and Vaccines market is projected to reach US$ 176440 million in 2034, increasing from US$ 95480 million in 2022, with the CAGR of 9.0% during the period of 2024 to 2034. Demand from Newborn and Infant are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pediatric Drugs and Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pediatric Drugs and Vaccines key manufacturers include Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA) and Actelion Pharmaceuticals, etc. Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA) are top 3 players and held % sales share in total in 2022.
Pediatric Drugs and Vaccines can be divided into Diphtheria, Influenza, Hepatitis and Pneumococcal Diseases, etc. Diphtheria is the mainstream product in the market, accounting for % sales share globally in 2022.
Pediatric Drugs and Vaccines is widely used in various fields, such as Newborn, Infant and Child,, etc. Newborn provides greatest supports to the Pediatric Drugs and Vaccines industry development. In 2022, global % sales of Pediatric Drugs and Vaccines went into Newborn filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Drugs and Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pediatric Drugs and Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pediatric Drugs and Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pediatric Drugs and Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pediatric Drugs and Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pediatric Drugs and Vaccines introduction, etc. Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pediatric Drugs and Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices